Page 27 - DIAGEN-EN
P. 27

primeFISH Products               Hematology

                                                                               HEMATOLOGY
                                                                                              PANEL



                                                                               17-009 AFF1-MLL t(4;11)



          Translocations involving the KMT2A gene are detected in   KMT2A gene. The most common translocation involving
          approximately 5-6% of all acute myeloid leukemias (AML)   the KMT2A gene in acute lymphoblastic leukemia (ALL) is
          and 5-10% of all acute lymphoblastic leukemias (ALL). The   the t(4;11)(q21;q23.3), which involves the KMT2A (lysine
          frequency of translocations involving the KMT2A gene is   methyltransferase 2A) gene located at 11q23.3 and the
          significantly higher in infants with AML (50%) and ALL (80%).   AFF1 (AF4/FMR2 family member 1) gene located at 4q21.3.
          Over 30 fusion partners have been documented for the
















                                                                                        TRANSLOCATION




                                            SHGC-50681     RH59180
                                                     3'  5'
                                         Cent                     Tel
                                                    AFF1
                                                    854 kb


                  4q21.2-q22.1            WI-9069          D11S797                   NORMAL
                                                    5'  3'
                                        Cent                     Tel
                                                   KMT2A

                                                   485 kb
                                                                                  TRANSLOCATION




                                   11q23.3


                                                       (Not to scale)



                                                                                             References
                                                                     De Braekeleer M, et al. (2005) Anticancer Res 25: 1931-44.
                                                                     Ford DJ & Dingwall AK (2015) Cancer Genet 208(5): 178-91.  www.diagen.com.tr
                                                                              Keefe JG, et al. (2010) J Mol Diagn 12: 441-52.
                                           Arsham, MS., Barch, MJ. and Lawce HJ. (eds.) (2017) The AGT Cytogenetics Laboratory Manual. New
                                                                                        Jersey: John Wiley & Sons Inc.
                                                                                 Kumar et al., Leuk Res. 2011;35(3):305-9


                                                                                           PRODUCT CATALOGUE    27
   22   23   24   25   26   27   28   29   30   31   32